Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LFMT and Biologic Therapy for Ulcerative Colitis
NCT05327790Phase 2Recruiting
- Sponsor
- University of Alberta
- Start
- Jun 2022
- Primary completion
- Mar 2027
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 2 trial of Lyophilized Fecal Microbiota Transplantation in ulcerative colitis (UC), sponsored by University of Alberta. Started Jun 2022; status: recruiting.
02
Drugs
Lyophilized Fecal Microbiota Transplantation
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT05327790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05327790.